Pleomorph poorly differentiated endocrine carcinoma of the rectum

Virchows Archiv

Volumn 442, Issue 6, 2003, Pages 605-610

  Crafa, Pellegrino ^a   Milione, Massimo ^a   Azzoni, Cinzia ^a   Pilato, Francesco Paolo ^a   Pizzi, Silvia ^a   Bordi, Cesare ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Pleomorph tumor; Poorly differentiated endocrine carcinoma; Rectum

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; SOMATOSTATIN DERIVATIVE; STEM CELL FACTOR;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; GENE EXPRESSION; GENE LOCUS; GIANT CELL; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROSATELLITE MARKER; POORLY DIFFERENTIATED ENDOCRINE CARCINOMA; PRIORITY JOURNAL; RECTUM CARCINOMA;

EID: 0038346308     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0807-1     Document Type: Article

References (10)

1. Canavese G, Azzoni C, Pizzi S, Corleto VD, Pasquali C, Davoli C, Crafa P, Delle Fave G, Bordi C (2001) p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. Hum Pathol 32:1094-1101
2. D'Adda T, Pizzi S, Azzoni C, Bottarelli L, Crafa P, Pasquali C, Davoli C, Corleto VD, Delle Fave G, Bordi C (2002) Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol 33:322-329
3. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CDM, Joensuu H (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480
4. Grabowski P, Schonfelder J, Ahnert Hilger G, Foss HD, Heine B, Schindler I, Stein H, Berger G, Zeitz M, Scherubl H (2002) Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 441:256-263
5. Miettinen M (1993) Keratin immunohistochemistry: update of applications and pitfalls. Pathol Annu 28:113-143
6. Rindi G, Azzoni C, La Rosa S, Klersy C, Paolotti D, Rappel S, Stolte M, Capella C, Bordi C, Solcia E (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116:532-542
7. Roncaroli F, Montironi R, Feliciotti F, Losi L, Eusebi V (1995) Sarcomatoid carcinoma of the anorectal junction with neuroendocrine and rhabdomyoblastic features. Am J Surg Pathol 19:217-223
8. Savage DG, Antman KH (2002) Drug therapy: imatinib mesylate - a new oral targeted therapy. N Engl J Med 346:683-693
9. Sekido Y, Fong KM, Minna JD (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta 1378:F21-F59
10. Solcia E, Klöppel G, Sobin LH (2000) Histological typing of endocrine tumours, 2nd edn, Springer, Berlin Heidelberg New York